AI assistant
Sending…
EyePoint Pharmaceuticals, Inc. — Director's Dealing 2012
Dec 14, 2012
32254_dirs_2012-12-14_2e5520ac-5d9a-42bf-bae5-7b5e548708c8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2012-12-14
Reporting Person: Mazzo David J (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-12-14 | Employee Stock Option (right to buy) | $2.14 | A | 45000 | Acquired | 2022-07-18 | Common Stock (45000) | Direct |
More from EyePoint Pharmaceuticals, Inc.
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 6
Investor Presentation
2026
Apr 13
Director's Dealing
2026
Mar 24
Legal Proceedings Report
2026
Mar 20
Regulatory Filings
2026
Mar 4
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 18
Major Shareholding Notification
2026
Feb 12
Director's Dealing
2026
Jan 7